Home » Topics » Regulatory

Regulatory
RSS

FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease

July 1, 2009

FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion

June 22, 2009

FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS

June 18, 2009

FDA approves Besivance for bacterial conjunctivitis

June 2, 2009

European Commission grants marketing authorization to HRA Pharma's ellaOne

May 27, 2009

FDA approves Adcirca tablets for pulmonary arterial hypertension

May 27, 2009

FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia

May 22, 2009

European Commission approves Qutenza for peripheral neuropathic pain

May 22, 2009

FDA approves UCB's pegylated anti-TNF Cimzia for rheumatoid arthritis

May 14, 2009

FDA grants marketing approval to Vanda's Fanapt for schizophrenia

May 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...